Grant RadarWorldwide funding

Browse grants Log in Get started

Health ClosedHT942526BCRPBTA3

DoW Breast Cancer, Breakthrough Award Level 3

Defense Health Agency Contracting Activity - DHACA opportunity HT942526BCRPBTA3

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

Defense Health Agency Contracting Activity - DHACAHT942526BCRPBTA3Grants.gov

Related Grants

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Amount not stated

11 Aug 2027(278d)

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Amount not stated

07 May 2028(548d)

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Amount not stated

26 Sep 2028(690d)

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (Clinical Trials Optional)

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

30 September 2026

Opens: 4 May 2026

Programme Details

Programme Code

HT942526BCRPBTA3